Aarkstore Enterprise-Premenstrual Syndrome – Pipeline Review, H1 2012|| Market Research

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Premenstrual Syndrome – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Premenstrual Syndrome - Pipeline Review, H1 2012,
provides an overview of the Premenstrual Syndrome therapeutic pipeline. This
report provides information on the therapeutic development for Premenstrual
Syndrome, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Premenstrual Syndrome. Premenstrual Syndrome - Pipeline
Review, H1 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Premenstrual Syndrome.
- A review of the Premenstrual Syndrome products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

2. - A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hypercalcemia Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hypercalcemia 7
Hypercalcemia Therapeutics under Development by Companies 9
Hypercalcemia Therapeutics under Investigation by Universities/Institutes 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Hypercalcemia Therapeutics – Products under Development by Companies 13
Hypercalcemia Therapeutics – Products under Investigation by
Universities/Institutes 14
Companies Involved in Hypercalcemia Therapeutics Development 15
Med Discovery SA 15
Hypercalcemia – Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
Parathyroid Hormone (1-34) - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
MDAB16 - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23

3. Hypercalcemia Therapeutics - Dormant Products 24
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Vasculitis – Pipeline Review, H1 2012
Wrinkles – Pipeline Review, H1 2012
Premenstrual Syndrome – Pipeline Review, H1 2012
Hypercalcemia – Pipeline Review, H1 2012
Chicken Pox – Pipeline Review, H1 2012
Hypereosinophilic Syndrome – Pipeline Review, H1 2012
Familial Adenomatous Polyposis Coli – Pipeline Review, H1 2012
Tinnitus – Pipeline Review, H1 2012
Shock – Pipeline Review, H1 2012

4. Influenza B Infections – Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com